Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Report Delivery in PDF, Excel, PowerPoint, and interactive dashboard formats for executive, procurement, and operational planning use
doi: 10.1097/mcg.0000000000001485
No data transparency If you cant see whos progressing, whos escalating doses, or whos ready to stop you cant manage the benefit effectively
According to SURMOUNT-4 trial data (2024), patients on Zepbound (Tirzepatide 15mg) maintained an average 21% body weight loss over 88 weekssignificantly higher than Semaglutide (Wegovy)s 15% in similar trials
Almost all patients used Medicare Part D insurance (96.6%)
US$ 28.23
US$ 29.94
US$ 20.97
US$ 26.75
US$ 24.33
US$ 28.32
US$ 27.89
US$ 25.36
US$ 26.22
US$ 29.14
